These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2323153)

  • 1. Clinical pharmacokinetics in the drug regulatory process.
    Salmonson T; Rane A
    Clin Pharmacokinet; 1990 Mar; 18(3):177-83. PubMed ID: 2323153
    [No Abstract]   [Full Text] [Related]  

  • 2. [Age-related changes in pharmacokinetics and pharmacodynamics].
    Akishita M
    Nihon Rinsho; 2013 Nov; 71(11):1888-91. PubMed ID: 24397155
    [No Abstract]   [Full Text] [Related]  

  • 3. Practical review of pharmacology concepts.
    Janda SM; Fagan NL
    Urol Nurs; 2010; 30(1):15-20. PubMed ID: 20359141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology. Drugs in children.
    Rylance G
    Br Med J (Clin Res Ed); 1981 Jan; 282(6257):50-1. PubMed ID: 6778567
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial. Role of Drug Transport and Pharmacokinetics in Drug Efficacy and Safety Part 1.
    Liu C; He X
    Curr Drug Metab; 2015; 16(9):730-1. PubMed ID: 26630904
    [No Abstract]   [Full Text] [Related]  

  • 6. ICH discussion on pharmacokinetics and toxicokinetics and contributors.
    Ohno Y
    Drug Metab Pharmacokinet; 2013; 28(5):379-82. PubMed ID: 24162438
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetic consequences of aging].
    Scarpignato C; Cavaggioni AL
    Farmaco Prat; 1981 Mar; 36(3):111-28. PubMed ID: 7011841
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of pharmacokinetics in drug safety evaluation.
    Singhvi SM; Keim GR; Migdalof BH
    Regul Toxicol Pharmacol; 1985 Mar; 5(1):3-17. PubMed ID: 3991931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic proposals for avoiding toxic interactions with drugs for clinical use during development and after marketing of a new drug: pharmacokinetic consideration.
    Sugiyama Y; Iwatsubo T; Ueda K; Ito K
    J Toxicol Sci; 1996 Dec; 21(5):309-16. PubMed ID: 9035043
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of membrane transporters in the safety profile of drugs.
    Lee EJ; Lean CB; Limenta LM
    Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1369-83. PubMed ID: 19663740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internet resources for proteins associated with drug therapeutic effects, adverse reactions and ADME.
    Ji ZL; Sun LZ; Chen X; Zheng CJ; Yao LX; Han LY; Cao ZW; Wang JF; Yeo WK; Cai CZ; Chen YZ
    Drug Discov Today; 2003 Jun; 8(12):526-9. PubMed ID: 12821296
    [No Abstract]   [Full Text] [Related]  

  • 12. ADME-tox issues for the elderly.
    Hilmer SN
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1321-31. PubMed ID: 18798701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug use and effects in older adults in the United States.
    Potempa KM; Folta A
    Int J Nurs Stud; 1992 Feb; 29(1):17-26. PubMed ID: 1551750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FOOD - DRUG INTERACTIONS: TYPES AND MECHANISMS.].
    Lemina EY; Churyukanov VV
    Eksp Klin Farmakol; 2016; 79(11):41-44. PubMed ID: 29791108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and drug toxicity in elderly patients: a case for geriatric core data in clinical trials.
    Ritz P; Vellas B
    J Nutr Health Aging; 2007; 11(3):261-4. PubMed ID: 17508105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinically relevant adverse drug interactions].
    Martin-Facklam M; Haefeli WE
    Ther Umsch; 2000 Sep; 57(9):579-83. PubMed ID: 11036439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological principles: Part 2.
    Kanneh A
    Paediatr Nurs; 1998 May; 10(4):24-7. PubMed ID: 9687782
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug interactions. Mechanisms and clinical relevance].
    Klotz U; Beil W; Gleiter C; Drewelow B; Garbe E; Gillessen A; Mutschler E
    Internist (Berl); 2003 Nov; 44(11):1444-9. PubMed ID: 14689079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanisms of the realization of stereoselectivity in pharmacokinetics].
    Rumiantsev DO; Piotrovskiĭ VK
    Eksp Klin Farmakol; 1994; 57(3):65-9. PubMed ID: 8049624
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design.
    Lee CA; O'Connor MA; Ritchie TK; Galetin A; Cook JA; Ragueneau-Majlessi I; Ellens H; Feng B; Taub ME; Paine MF; Polli JW; Ware JA; Zamek-Gliszczynski MJ
    Drug Metab Dispos; 2015 Apr; 43(4):490-509. PubMed ID: 25587128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.